Ben Cannon
20 years in Private Equity and Venture Capital, investing in leading companies across a variety of sub-sectors. Few investors have invested across the continuum of the most transformative technologies to the most established companies, allowing for a unique birds-eye view of the Healthcare space, among others.
​
After being a Principal of some of the largest investment firms ($10-$300 Billion in AUM) investing in private companies, Ben Cannon launched CUE GROWTH to serve a needed area within the Healthcare space, as "one size" does not reach the most attractive areas within the different sub-sectors and complicated ecosystem that is Healthcare.
Recent activity includes CUE Growth being the largest dollar investor and multi-time Co-Lead of Amplitude Vascular Systems in the Intravascular Lithotripsy (IVL) space, and separately, Co-Leading the recent investment in Field Medical (Pulsed Field Ablation), alongside several $100 Billion+ market cap Strategics.
Known as "the Mayor" within certain New York City circles, Alyssa started her career nearly 20 years ago at Morgan Stanley and Jefferies, serving investment bankers through their operational and human capital needs.
​
As a Co-Founder of Cue Growth, she is involved with all Operational and Investor Relations activities of the investment firm. There are few people liked more than Alyssa, who engages in dialogue with all participants in Cue's ecosystem including Limited Partners, Executives of Current and potential Portfolio Companies, and other third parties engaged with the investment firm.
She enjoys the unique relationships that allow Cue to invest in the most impactful medical devices and healthcare companies.